Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Friday. The firm issued a hold rating on the stock.

Retractable Technologies Trading Up 0.4 %

NYSE:RVP opened at $1.09 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.41 and a current ratio of 8.28. The firm has a market cap of $32.63 million, a price-to-earnings ratio of -4.54 and a beta of 2.11. Retractable Technologies has a 52 week low of $0.95 and a 52 week high of $1.70. The firm has a 50-day moving average price of $1.16 and a two-hundred day moving average price of $1.15.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. WealthTrust Axiom LLC grew its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 126,533 shares of the company’s stock after acquiring an additional 27,500 shares during the period. WealthTrust Axiom LLC owned about 0.42% of Retractable Technologies worth $151,000 at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.